320
Participants
Start Date
September 29, 2025
Primary Completion Date
June 30, 2028
Study Completion Date
June 30, 2029
wSp vaccine
wSp vaccine will be administered as intramuscular (IM) injections of 0.5 mL (thus 1 mg total protein). wSp vaccine is supplied as single-dose glass vials in saline (0.9% sodium chloride) at 2 mg protein/mL, with aluminum hydroxide at 1.2 mg elemental Al/mL. Dose 1 will be given in the left thigh at 7 months of age, and dose 2 will be given in the right thigh at 9 months of age.
Saline (0.9% NaCl)
Saline will be administered as intramuscular (IM) injections of 0.5 mL. Dose 1 will be given in the left thigh at 7 months of age and dose 2 will be given in the right thigh at 9 months of age.
RECRUITING
Western New York Geneva Pediatrics, Rochester
RECRUITING
Bay Creek Pediatrics, Rochester
RECRUITING
Rochester Medical Group General Pediatric Associates, Rochester
RECRUITING
Panorama Pediatrics, Rochester
Collaborators (1)
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Rochester General Hospital
OTHER
Serum Institute of India Pvt. Ltd.
INDUSTRY
Alira Health
OTHER
Serum Life Science Europe GmbH
INDUSTRY